Asset Details
Do you wish to reserve the book?
Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists
Do you wish to request the book?
Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists
2024
Overview
Apart from the legs, restless legs syndrome (RLS) also affects the arms, head, neck, face, oral cavity, genital area, abdomen, intestines and bladder. RLS is also linked to several comorbid diseases, including headache disorders. Its association with dizziness has never been explored. We are reporting on two patients with RLS who also had a history of chronic dizziness. The treatment with levodopa or dopamine agonists completely alleviated both RLS and dizziness. We propose that RLS-like symptoms in the head may be experienced as dizziness and that dizziness may be part of the symptom complex of RLS. A large number of patients with chronic dizziness remain undiagnosed in clinical practice. We suggest exploring the history of RLS in patients presenting with chronic dizziness. Such patients may respond to levodopa or dopamine agonists. Because the response was seen in only two patients, a prospective placebo-controlled trial is needed to confirm these findings.
Publisher
BMJ Publishing Group Ltd,BMJ Publishing Group LTD,BMJ Publishing Group
Subject
/ Case Reports: Unusual association of diseases/symptoms
/ Dizziness - chemically induced
/ Dopamine
/ Dopamine Agonists - adverse effects
/ Gait
/ Humans
/ Insomnia
/ Legs
/ Movement disorders (other than Parkinsons)
/ Patients
/ Restless Legs Syndrome - complications
/ Restless Legs Syndrome - diagnosis
/ Restless Legs Syndrome - drug therapy
/ Vitamins
/ Walking
